{"id":"direct-renin-inhibitor","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Renin catalyzes the conversion of angiotensinogen to angiotensin I, the first and rate-limiting step of the RAAS cascade. By directly inhibiting renin at its active site, this drug prevents downstream generation of angiotensin II, a potent vasoconstrictor and aldosterone stimulator. This results in vasodilation, reduced sodium retention, and lower blood pressure.","oneSentence":"A direct renin inhibitor blocks the enzyme renin, preventing the initial step of the renin-angiotensin-aldosterone system (RAAS) and reducing blood pressure.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T02:33:14.398Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT04364984","phase":"","title":"ARB, ACEi, DRi Effects on COVID-19 Course Disease","status":"COMPLETED","sponsor":"Medical Practice Prof D. Ivanov","startDate":"2020-04-01","conditions":"Hypertension, COVID-19","enrollment":112},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT01461499","phase":"PHASE4","title":"Shiga Microalbuminuria Reduction Trial-2","status":"COMPLETED","sponsor":"Shiga University","startDate":"2011-10","conditions":"Type 2 Diabetes Mellitus, Hypertension","enrollment":237},{"nctId":"NCT01349114","phase":"PHASE4","title":"Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2011-06","conditions":"Diabetes, Pre-hypertension, Hypertension","enrollment":21},{"nctId":"NCT02909166","phase":"PHASE3","title":"Role of ALiskiren, a Direct Renin Inhibitor, in Preventing Atrial Fibrillation in Patients With a Pacemaker; RALF.","status":"UNKNOWN","sponsor":"Mika Lehto","startDate":"2012-01","conditions":"Atrial Fibrillation","enrollment":70},{"nctId":"NCT01454583","phase":"","title":"Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany","status":"COMPLETED","sponsor":"Stiftung Institut fuer Herzinfarktforschung","startDate":"2008-10","conditions":"Arterial Hypertension","enrollment":15337},{"nctId":"NCT02446548","phase":"NA","title":"Influence of Aliskiren on Albuminuria After Kidney Transplantation","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2013-03","conditions":"Albuminuria","enrollment":18},{"nctId":"NCT01129557","phase":"PHASE4","title":"Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease","status":"TERMINATED","sponsor":"Columbia University","startDate":"2009-09","conditions":"Proteinuric Kidney Disease, Diabetic Nephropathy, Hypertensive Nephrosclerosis","enrollment":46},{"nctId":"NCT01432106","phase":"PHASE1","title":"The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome","status":"WITHDRAWN","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Hypertension, Metabolic Syndrome","enrollment":""},{"nctId":"NCT01284114","phase":"PHASE4","title":"Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","sponsor":"Jichi Medical University","startDate":"2011-02","conditions":"Hypertension, Chronic Kidney Disease","enrollment":23},{"nctId":"NCT01541267","phase":"PHASE4","title":"The Effect of Various Types of the Renin-angiotensin-aldosterone System Blockade on Proteinuria","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2009-12","conditions":"Chronic Kidney Disease, Proteinuria","enrollment":20},{"nctId":"NCT00542269","phase":"PHASE4","title":"Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome","status":"TERMINATED","sponsor":"Novartis","startDate":"2008-03","conditions":"Hypertension With Metabolic Syndrome","enrollment":178},{"nctId":"NCT01298258","phase":"NA","title":"Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2010-07","conditions":"Heart Failure","enrollment":120},{"nctId":"NCT01156207","phase":"PHASE4","title":"Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2010-07","conditions":"Heart Failure","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":428,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["no other drug as RAS inhibitor"],"phase":"phase_2","status":"active","brandName":"Direct renin inhibitor","genericName":"Direct renin inhibitor","companyName":"Medical Practice Prof D. Ivanov","companyId":"medical-practice-prof-d-ivanov","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A direct renin inhibitor blocks the enzyme renin, preventing the initial step of the renin-angiotensin-aldosterone system (RAAS) and reducing blood pressure. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}